Dr. Matt Soroush, M.D. F.A.C.S.  - Pennsylvania Urologist

EDUCATION:

• 1999-2000 Chief Resident Urology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
• 1996-2000 Resident in Urology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
• 1994-1996 Resident in General Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
• 1990-1994 Doctor of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia
• 1986-1990 Bachelor of Arts with Distinction, University of Virginia, Charlottesville, Virginia

CERTIFICATION:

• Pennsylvania Medical Society Continuing Medical Education Certification 6/2003
• Certification In Human Subject Research as Sponsored by The Collaborative IRB Training Initiative and The University of Miami

SOCIETIES:

• Mid-Atlantic Section - American Urologic Association Society of Laparoendoscopic Surgeons
• Philadelphia Urologic Society
• Urologic Association of Pennsylvania
• Endourologic Society
• Pennsylvania Medical Society American College of Surgeons
• Millenium Urology Group

AWARDS AND HONORS

• University of Virginia Echols Scholar University of Virginia Intermediate Honors
• Alpha Epsilon Delta-University of Virginia

CLINICAL RESEARCH:

Clinical Trials: Investigator

• Autologous PAP-Loaded Dendretic Cell Vaccine (APC 8015, Provenge) in Patients With Non- Metastatic Prostate Cancer Who Experience PSA Elevation Following Radical Prostatectomy:
• A Randomized, Controlled, Double Blind Study (Dendreon P11) A Prospective, Randomized, Controlled, Multicenter Trial of the Memokath 044TW Thermoexpandable Stent For Maintaining Urethral Patency in Patients After Dilatation or Internal Urethrotomy of Recurrent Stricture of the Bulbar Urethra (Engineers and Doctors) A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Dutasteride 0.5mg Administered Orally Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable Prostate Cancer (GlaxoSmithKline)
• Study of Duloxetine HCL in Women of Different Demographic Characteristics and Comorbidities With Stress Incontinence: Evaluation of Efficacy and Safety (Eli Lilly)

BASIC SCIENCE RESEARCH:

• Student Research Fellow, Laboratory of Pathology, Tumor Invasion and Metastasis Section, National Cancer Institute, National Institutes of Health, Bethesda, Md. 1988-1991

SCIENTIFIC PUBLICATIONS AND PRESENTATIONS

Peer-Reviewed Papers

• Stracke, M.L., Soroush, M., Liotta, LA, Schiffman, E: Cytoskeleton Agents Inhibit Motility and Adherence of Human Tumor Cells, Kidnay International 43: 151-157, 1993Soroush, M., Bagley, D.H., Ureteroscopic Retrograde Endopyelotomy, Techniques in Urology, 4:2, pp. 77-82, 1998
• Soroush, M., Hirsch, I.H., Das, A., Maurer, S., Multicomponent Penile Prosthesis Implantation Under Regional Anesthesia, Techniques in Urology, 5:2, 1999
• Shupp Byrne, D., Sedor, J.F., Soroush, M., McCue, P.A., Mulholland, S.G., Interaction of Bladder Glycoprotein GP51 with Uropathogenic Bacteria, The Journal of Urology, Vol. 165 pp 1342-1346, April 2001

Peer-Reviewed Abstracts

• Soroush, M., Ismail, M., Peterson, R.O., Newschaffer, C., Valicenti, R.K., Gomella, L.G., Radiation Treatment Following Radical Prostatectomy: Does It Add To Patients Morbidity? Mid-Atlantic Section, American Urologic Association Annual Meeting, W. Palm Beach, Fl., 1998

CHAPTERS AND BOOKS

• Soroush, M., ed: Urology Chapter. Surgical Recall, Lippincott, Williams and Wilkins, Philadelphia, 1993.
• Soroush, M., : (Contributor) In Gomella, L.G. and Dambro, Mark, M.D. eds, 5 Minute Urology Consult, Lippincott, Williams, and Wilkins, Philadelphia, 2000.

PRESENTATIONS AND INVITED LECTURES

• Ureteroscopic Retrograde Endopyelotomy, Thomas Jefferson University Department of Urology Grand Rounds, Philadelphia, Pa., 9/97
• Radiation Treatment Following Radical Prostatectomy: Does It Add To Patient Morbidity?, Mid-Atlantic Section, American Urologic Association, West Palm Beach, Fl. , 10/98
• Update In Erectile Dysfunction, Bryn Mawr Hospital Department of Family Medicine Lecture Series 3/01 The Use of PSA In Prostate Cancer Screening, The Bryn Mawr Hospital Department of Family Medicine Lecture Series 4/02
• Moderator, Urology Lecture Series, Department of Urology, Thomas Jefferson Universtiy, Philadelphia, Pa. 8/03
• Overactive Bladder in the Primary Care Setting, Community Lecture Series, Havertown, Pa., 1/04 Overview of the Current State of PDE5 Inhibitors in the Treatment of Erectile Dysfunction, Community Lecture Series, Devon, Pa., 2/04
• The Treatment of Erectile Dysfunction in the Primary Care Setting, Community Lecture Series, Radnor, Pa. 2/04
• Oral Therapy for Erectile Dysfunction, Community Lectue Series, Paoli, Pa., 3/04
• Benign Prostatic Hyperplasia: A Review of Medical Management, Scranton, Pa. 3/04
• The Treatment of Erectile Dysfunction in the Primary Care Setting, Bryn Mawr, Pa. 3/04 Advances In The Treatment of Interstitial Cystitis, Community Lecture Series, Haverford, Pa. 3/ 04
• The Treatment of Benign Prostatic Hyperplasia, Community Lecture Series, Reading, Pa. 4/04
• The Cardiovascular Safety Profile of PDE5 Inhibition:Fact vs. Myth, Community Lecture Series, 4/04
• The Latest Advances In Oral Therapy For Erectile Dysfunction, Community Outreach, King of Prussia, Pa. 4/04
• Benign Prostatic Hypertrophy: Management In The Primary Care Setting, Devon, Pa. 6/04